Crossmark

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors

Crossref DOI link: https://doi.org/10.1007/s10147-023-02345-7

Published Online: 2023-05-22

Published Print: 2023-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Naito, Yoichi

Mishima, Saori http://orcid.org/0000-0002-5922-1487
Akagi, Kiwamu

Hayashi, Naomi

Hirasawa, Akira

Hishiki, Tomoro

Igarashi, Ataru

Ikeda, Masafumi

Kadowaki, Shigenori

Kajiyama, Hiroaki

Kato, Motohiro

Kenmotsu, Hirotsugu

Kodera, Yasuhiro

Komine, Keigo

Koyama, Takafumi

Maeda, Osamu

Miyachi, Mitsuru

Nishihara, Hiroshi

Nishiyama, Hiroyuki

Ohga, Shouichi

Okamoto, Wataru

Oki, Eiji

Ono, Shigeru

Sanada, Masashi

Sekine, Ikuo

Takano, Tadao

Tao, Kayoko

Terashima, Keita

Tsuchihara, Katsuya

Yatabe, Yasushi

Yoshino, Takayuki

Baba, Eishi
License Information

Text and Data Mining valid from 2023-05-22

Version of Record valid from 2023-05-22
More Information

Article History

Received: 13 March 2023

Accepted: 13 April 2023

First Online: 22 May 2023

Declarations

:

: All committee members and peer review members were nominated by each Society, and the conflict of interest (COI) control is conducted by each Society’s regulation.

Document is current

Any future updates will be listed below